Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses

DOI: 10.1080/2162402X.2016.1146841

Keywords: CD8+ T cells, cell activation, dendritic cells, mTORC2, melanoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text